收费全文 | 5466831篇 |
免费 | 414779篇 |
国内免费 | 16759篇 |
耳鼻咽喉 | 78237篇 |
儿科学 | 173019篇 |
妇产科学 | 145677篇 |
基础医学 | 805688篇 |
口腔科学 | 155663篇 |
临床医学 | 504807篇 |
内科学 | 997566篇 |
皮肤病学 | 125871篇 |
神经病学 | 456551篇 |
特种医学 | 213798篇 |
外国民族医学 | 1455篇 |
外科学 | 815835篇 |
综合类 | 153435篇 |
现状与发展 | 24篇 |
一般理论 | 3038篇 |
预防医学 | 459723篇 |
眼科学 | 130896篇 |
药学 | 393126篇 |
28篇 | |
中国医学 | 14114篇 |
肿瘤学 | 269818篇 |
2021年 | 57280篇 |
2019年 | 59711篇 |
2018年 | 77426篇 |
2017年 | 59428篇 |
2016年 | 66256篇 |
2015年 | 78171篇 |
2014年 | 113009篇 |
2013年 | 178899篇 |
2012年 | 156140篇 |
2011年 | 166431篇 |
2010年 | 135262篇 |
2009年 | 134109篇 |
2008年 | 151741篇 |
2007年 | 163603篇 |
2006年 | 170164篇 |
2005年 | 164298篇 |
2004年 | 164619篇 |
2003年 | 154092篇 |
2002年 | 143574篇 |
2001年 | 219545篇 |
2000年 | 217958篇 |
1999年 | 194064篇 |
1998年 | 79248篇 |
1997年 | 73101篇 |
1996年 | 70918篇 |
1995年 | 66579篇 |
1994年 | 60578篇 |
1993年 | 55945篇 |
1992年 | 145350篇 |
1991年 | 139872篇 |
1990年 | 134575篇 |
1989年 | 130631篇 |
1988年 | 120914篇 |
1987年 | 118995篇 |
1986年 | 112570篇 |
1985年 | 109412篇 |
1984年 | 87363篇 |
1983年 | 76678篇 |
1982年 | 55189篇 |
1981年 | 50943篇 |
1980年 | 47675篇 |
1979年 | 78473篇 |
1978年 | 60139篇 |
1977年 | 52365篇 |
1976年 | 49025篇 |
1975年 | 49971篇 |
1974年 | 57577篇 |
1973年 | 55234篇 |
1972年 | 51996篇 |
1971年 | 47950篇 |
Objectives
Iatrogenic injury of the Profunda Femoris Artery (PFA) at time of hip fixation surgery can increase morbidity and mortality and prolong the hospital stay. This is an injury that tends to pass unnoticed as a cause of postoperative deterioration despite being frequently reported in the literature. Our study aims to describe the anatomy of the PFA in relation to the medial femoral cortex with specific emphasis on its orientation relative to the position of a sliding hip screw side plate construct. By doing so we are able to present clear guidance to orthopaedic surgeons on how to avoid iatrogenic PFA injury at the time of hip fracture fixation.Methods
Using Computed Tomography Angiographic (CTA) studies, the course of the PFA in relation to the medial femoral cortex was traced in 44 patients (28 males and 16 females) with mean age of 65.6 years. Coronal and axial CT sections were cross-linked to specify the position of the PFA at 1?cm intervals.Results
The course of the artery could be divided into three parts relative to a fixed reference point. Proximal and distal parts of the artery were in a safer position in comparison to the middle part of the artery that was found very close to the femoral cortex and along the coronal axis of the femur (mean angle 2.9° from the femoral coronal axis and 13.8?mm from the medial femoral cortex). Using the commercially available side plate constructs, this part of the artery corresponded to the distal part of the plate (third and fourth holes).Conclusion
Special attention needs to be practiced by the operating surgeon while drilling into the third and fourth holes of the side plate. 相似文献Background
Rosacea is a chronic inflammatory skin condition whose etiology has been linked to mast cells and the antimicrobial peptide cathelicidin LL-37. Individuals with refractory disease have demonstrated clinical benefit with periodic injections of onabotulinum toxin, but the mechanism of action is unknown.Objectives
To investigate the molecular mechanism by which botulinum toxin improves rosacea lesions.Methods
Primary human and murine mast cells were pretreated with onabotulinum toxin A or B or control. Mast cell degranulation was evaluated by β-hexosaminidase activity. Expression of botulinum toxin receptor Sv2 was measured by qPCR. The presence of SNAP-25 and VAMP2 was established by immunofluorescence. In vivo rosacea model was established by intradermally injecting LL-37 with or without onabotulinum toxin A pretreatment. Mast cell degranulation was assessed in vivo by histologic counts. Rosacea biomarkers were analyzed by qPCR of mouse skin sections.Results
Onabotulinum toxin A and B inhibited compound 48/80-induced degranulation of both human and murine mast cells. Expression of Sv2 was established in mouse mast cells. Onabotulinum toxin A and B increased cleaved SNAP-25 and decreased VAMP2 staining in mast cells respectively. In mice, injection of onabotulinum toxin A significantly reduced LL-37-induced skin erythema, mast cell degranulation, and mRNA expression of rosacea biomarkers.Conclusions
These findings suggest that onabotulinum toxin reduces rosacea-associated skin inflammation by directly inhibiting mast cell degranulation. Periodic applications of onabotulinum toxin may be an effective therapy for refractory rosacea and deserves further study. 相似文献Methods: Tumour and surrounding tissue were modeled by elliptical two- and three-dimensional computational phantoms having six different nanoparticle distributions. Nanoparticles were modeled as point heat sources having amplitude-dependent loss power. The total number of nanoparticles was fixed, and their spatial distribution and heat output were varied. Heat transfer was computed by solving the Pennes’ bioheat equation using finite element methods (FEM) with temperature-dependent blood perfusion. Local temperature was regulated using a proportional-integral-derivative (PID) controller. Tissue temperature, thermal dose and tissue damage were calculated. The required minimum thermal dose delivered to the tumor was kept constant, and heating power was adjusted for comparison of both the heating methods.
Results: Modulated power heating produced lower and more homogeneous temperature distributions than did constant power heating for all studied nanoparticle distributions. For a concentrated nanoparticle distribution, located off-center within the tumor, the maximum temperatures inside the tumor were 16% lower for modulated power heating when compared to constant power heating. This resulted in less damage to surrounding normal tissue. Modulated power heating reached target thermal doses up to nine-fold more rapidly when compared to constant power heating.
Conclusions: Controlling the temperature at the tumor-healthy tissue boundary by modulating the heating power of magnetic nanoparticles demonstrably compensates for a variable nanoparticle distribution to deliver effective treatment. 相似文献